Journal
NEPHRON CLINICAL PRACTICE
Volume 128, Issue 3-4, Pages 255-260Publisher
KARGER
DOI: 10.1159/000368587
Keywords
Lupus; Lupus nephritis; Glomerular disease; Treatment; Biologics
Categories
Ask authors/readers for more resources
This position paper critically analyzes the available controlled data regarding biologic therapy in lupus nephritis (LN). Rather than an exhaustive review of all published evidence, the stress is put on the unmet medical needs in LN, the design of trials aimed at testing the effect of a biologic in LN, the possible reasons for LN trial failures and the future of biological therapy in LN. (C) 2014 S. Karger AG, Basel
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
